We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$320M
Cap. Flow
+$267M
Cap. Flow %
17.84%
Top 10 Hldgs %
83.78%
Holding
30
New
8
Increased
6
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$137M
2
GMED icon
Globus Medical
GMED
+$111M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$50.3M
4
KROS icon
Keros Therapeutics
KROS
+$36.3M
5
MRP
Millrose Properties Inc
MRP
+$21.8M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$50.7M
2
SOLV icon
Solventum
SOLV
+$40.3M
3
MKL icon
Markel Group
MKL
+$13.2M
4
SLRN
ACELYRIN
SLRN
+$10.2M
5
NNI icon
Nelnet
NNI
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 44.49%
2 Industrials 15.54%
3 Financials 12.41%
4 Technology 10.81%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
26
Ovid Therapeutics
OVID
$433M
$433K 0.03%
1,311,362
-1,154,261
-47% -$348K
ACHC icon
27
Acadia Healthcare
ACHC
$2.8B
– –
-9,486
Closed -$288K
PCG icon
28
PG&E
PCG
$38.1B
– –
-2,950,000
Closed -$50.7M
SLRN
29
DELISTED
ACELYRIN
SLRN
– –
-4,142,640
Closed -$10.2M
TSVT
30
DELISTED
2seventy bio
TSVT
– –
-579,895
Closed -$2.86M
1
2

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
NDSIB
North Dakota State Investment Board Bismarck, North Dakota $2.31B AUM

Madison Avenue Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Madison Avenue Partners held 30 positions worth $1.5B, up 27% from $1.18B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Madison Avenue Partners deployed $267M of net new capital in Q2 2025, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Sandisk: 3,571,109 shares worth $162M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 36% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Solventum, an estimated $40.3M trimmed.

  • Madison Avenue Partners's largest Q2 2025 buy was Sandisk: 3,571,109 shares worth $162M.
  • Madison Avenue Partners added most to CARGO Therapeutics in Q2 2025, an estimated $17.5M increase.
  • Madison Avenue Partners's biggest Q2 2025 reduction was Solventum, cutting an estimated $40.3M.
  • Madison Avenue Partners fully exited PG&E in Q2 2025, selling an estimated $50.7M.
  • Madison Avenue Partners's ten largest holdings make up 84% of its $1.5B portfolio in Q2 2025.
  • Madison Avenue Partners opened 8 new positions and closed 4 in Q2 2025.
  • Madison Avenue Partners's portfolio value rose 27% quarter-over-quarter to $1.5B.

Based on Madison Avenue Partners's 13F filing for Q2 2025, filed 14 Aug 2025.